SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-044913
Filing Date
2019-08-08
Accepted
2019-08-08 16:34:29
Documents
4
Period of Report
2019-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-16864_18k.htm 8-K 34751
2 EX-10.1 a19-16864_1ex10d1.htm EX-10.1 85986
3 EX-99.1 a19-16864_1ex99d1.htm EX-99.1 87751
4 GRAPHIC g168641mmi001.jpg GRAPHIC 3846
  Complete submission text file 0001104659-19-044913.txt   215237
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 191010072
SIC: 2834 Pharmaceutical Preparations